Valproate Should Be Removed From FDA Pediatric Drug List - GPIA
Executive Summary
Inclusion of valproate (Abbott's Depacon) on FDA's draft list of approved drugs for which additional pediatric information may produce health benefits is "of particular concern" to the Generic Pharmaceutical Industry Association.